DCP
DSM Capital Partners’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122M | Sell |
1,760,978
-295,609
| -14% | -$20.4M | 1.8% | 18 |
|
|
2025
Q1 | $143M | Buy |
2,056,587
+49,175
| +2% | +$3.41M | 2.5% | 12 |
|
|
2024
Q4 | $173M | Buy |
2,007,412
+286,912
| +17% | +$24.7M | 2.67% | 11 |
|
|
2024
Q3 | $205M | Buy |
1,720,500
+126,579
| +8% | +$15.1M | 3.13% | 10 |
|
|
2024
Q2 | $228M | Buy |
1,593,921
+1,593,303
| +257,816% | +$227M | 3.3% | 9 |
|
|
2024
Q1 | $79.4K | Buy |
618
+166
| +37% | +$21.3K | ﹤0.01% | 58 |
|
|
2023
Q4 | $46.8K | Buy |
+452
| New | +$46.8K | ﹤0.01% | 66 |
|
|
2016
Q1 | – | Sell |
-1,490
| Closed | -$87K | – | 41 |
|
|
2015
Q4 | $87K | Hold |
1,490
| – | – | ﹤0.01% | 39 |
|
|
2015
Q3 | $81K | Hold |
1,490
| – | – | ﹤0.01% | 39 |
|
|
2015
Q2 | $82K | Sell |
1,490
-485
| -25% | -$26.7K | ﹤0.01% | 40 |
|
|
2015
Q1 | $105K | Hold |
1,975
| – | – | ﹤0.01% | 38 |
|
|
2014
Q4 | $84K | Hold |
1,975
| – | – | ﹤0.01% | 43 |
|
|
2014
Q3 | $94K | Hold |
1,975
| – | – | ﹤0.01% | 75 |
|
|
2014
Q2 | $91K | Buy |
+1,975
| New | +$91K | ﹤0.01% | 76 |
|